These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 2471266)

  • 61. Hepatitis B virus (HBV)-specific cytotoxic T-cell (CTL) response in humans: characterization of HLA class II-restricted CTLs that recognize endogenously synthesized HBV envelope antigens.
    Penna A; Fowler P; Bertoletti A; Guilhot S; Moss B; Margolskee RF; Cavalli A; Valli A; Fiaccadori F; Chisari FV
    J Virol; 1992 Feb; 66(2):1193-8. PubMed ID: 1731098
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Murine cytotoxic T lymphocyte recognition of individual influenza virus proteins. High frequency of nonresponder MHC class I alleles.
    Bennink JR; Yewdell JW
    J Exp Med; 1988 Nov; 168(5):1935-9. PubMed ID: 3263469
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Dendritic cells and antigen presentation in the regulation of cytotoxic T lymphocyte responses against viruses and transplantation antigens.
    Melief CJ; Boog CJ; Vasmel WL; Boes J; Voordouw AC; Kast WM
    Ann N Y Acad Sci; 1988; 532():280-91. PubMed ID: 2845847
    [No Abstract]   [Full Text] [Related]  

  • 64. HLA-restricted recognition of viral antigens in HLA transgenic mice.
    Kievits F; Ivanyi P; Krimpenfort P; Berns A; Ploegh HL
    Nature; 1987 Oct 1-7; 329(6138):447-9. PubMed ID: 2821399
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Overlapping epitopes that are recognized by CD8+ HLA class I-restricted and CD4+ class II-restricted cytotoxic T lymphocytes are contained within an influenza nucleoprotein peptide.
    Carreno BM; Turner RV; Biddison WE; Coligan JE
    J Immunol; 1992 Feb; 148(3):894-9. PubMed ID: 1370522
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Differences in antigen presentation to MHC class I-and class II-restricted influenza virus-specific cytolytic T lymphocyte clones.
    Morrison LA; Lukacher AE; Braciale VL; Fan DP; Braciale TJ
    J Exp Med; 1986 Apr; 163(4):903-21. PubMed ID: 3485173
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Defective presentation to class I-restricted cytotoxic T lymphocytes in vaccinia-infected cells is overcome by enhanced degradation of antigen.
    Townsend A; Bastin J; Gould K; Brownlee G; Andrew M; Coupar B; Boyle D; Chan S; Smith G
    J Exp Med; 1988 Oct; 168(4):1211-24. PubMed ID: 2459295
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Antigen presentation: structural themes and functional variations.
    Braciale TJ; Braciale VL
    Immunol Today; 1991 Apr; 12(4):124-9. PubMed ID: 1711855
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A transient transfection system for identifying biosynthesized proteins processed and presented to class I MHC restricted T lymphocytes.
    Eisenlohr LC; Yewdell JW; Bennink JR
    J Immunol Methods; 1992 Sep; 154(1):131-8. PubMed ID: 1401939
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Resistance to H-2-restricted but not to allo-H2-specific graft and cytotoxic T lymphocyte responses in lymphoma mutant.
    Ohlén C; Bastin J; Ljunggren HG; Foster L; Wolpert E; Klein G; Townsend AR; Kärre K
    J Immunol; 1990 Jul; 145(1):52-8. PubMed ID: 2358681
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Class I antigen presentation.
    Jelachich ML; Biddison WE
    Year Immunol; 1989; 4():41-58. PubMed ID: 2522701
    [No Abstract]   [Full Text] [Related]  

  • 72. Inhibition by brefeldin A of the specific B cell antigen presentation to MHC class II-restricted T cells.
    Kakiuchi T; Takatsuki A; Watanabe M; Nariuchi H
    J Immunol; 1991 Nov; 147(10):3289-95. PubMed ID: 1940337
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Targeting tumour cells with defects in the MHC Class I antigen processing pathway with CD8+ T cells specific for hydrophobic TAP- and Tapasin-independent peptides: the requirement for directed access into the ER.
    Aladin F; Lautscham G; Humphries E; Coulson J; Blake N
    Cancer Immunol Immunother; 2007 Aug; 56(8):1143-52. PubMed ID: 17143611
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The predominance of CD8+ T cells after infection with measles virus suggests a role for CD8+ class I MHC-restricted cytotoxic T lymphocytes (CTL) in recovery from measles. Clonal analyses of human CD8+ class I MHC-restricted CTL.
    van Binnendijk RS; Poelen MC; Kuijpers KC; Osterhaus AD; Uytdehaag FG
    J Immunol; 1990 Mar; 144(6):2394-9. PubMed ID: 2107259
    [TBL] [Abstract][Full Text] [Related]  

  • 75. HIV-1 envelope protein is expressed on the surface of infected cells before its processing and presentation to class II-restricted T lymphocytes.
    Callahan KM; Rowell JF; Soloski MJ; Machamer CE; Siliciano RF
    J Immunol; 1993 Sep; 151(6):2928-42. PubMed ID: 8376762
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Epitope-specific enhancement of antigen presentation by invariant chain.
    Momburg F; Fuchs S; Drexler J; Busch R; Post M; Hämmerling GJ; Adorini L
    J Exp Med; 1993 Oct; 178(4):1453-8. PubMed ID: 7690835
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Presentation by a major histocompatibility complex class I molecule of nucleoprotein peptide expressed in two different genes of an influenza virus transfectant.
    Isobe H; Moran T; Li S; Young A; Nathenson S; Palese P; Bona C
    J Exp Med; 1995 Jan; 181(1):203-13. PubMed ID: 7528768
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Recognition by major histocompatibility complex class I-restricted cytolytic T lymphocytes of cells expressing vaccinia-encoded viral and class I proteins.
    Andrew ME; Coupar BE; Boyle DB; Blanden RV
    Eur J Immunol; 1987 Oct; 17(10):1515-8. PubMed ID: 3500060
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Presentation of viral antigen by MHC class I molecules is dependent on a putative peptide transporter heterodimer.
    Spies T; Cerundolo V; Colonna M; Cresswell P; Townsend A; DeMars R
    Nature; 1992 Feb; 355(6361):644-6. PubMed ID: 1538752
    [TBL] [Abstract][Full Text] [Related]  

  • 80. HLA class I and II molecules present influenza virus antigens with different kinetics.
    Kuijpers KC; van Kemenade FJ; Hooibrink B; Neefjes JJ; Lucas CJ; van Lier RA; Miedema F
    Eur J Immunol; 1992 Sep; 22(9):2339-45. PubMed ID: 1516624
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.